Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PROC”

67 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 67 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05081609
What this trial is testing

Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
Advanced Solid TumorLocally Advanced Solid TumorMetastatic Solid Tumor+10 more
Ascendis Pharma Oncology Division A/S 320
Not applicableStudy completedNCT00828243
What this trial is testing

Genetic Regulation of Surfactant Deficiency

Who this might be right for
Respiratory Distress Syndrome, Newborn
Washington University School of Medicine 525
Testing effectiveness (Phase 2)Study completedNCT03657043
What this trial is testing

Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208)

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Seagen Inc. 98
Not applicableStudy completedNCT03147352
What this trial is testing

Prognosis and Treatment of Necrotizing Soft Tissue Infections: A Prospective Cohort Study

Who this might be right for
Necrotizing Soft Tissue InfectionNecrotizing FascitisGas Gangrene+1 more
Ole Hyldegaard 260
Not applicableUnknownNCT06182501
What this trial is testing

Interference by Activated Protein C Resistance in the Determination of Protein S Activity

Who this might be right for
Resistance to Activated Protein C in the Determination of Protein S Activity
University Hospital, Strasbourg, France 9,470
Large-scale testing (Phase 3)Study completedNCT00157118
What this trial is testing

Efficacy and Safety Study of Protein C Concentrate in Subjects With Severe Congenital Protein C Deficiency

Who this might be right for
Protein C Deficiency
Baxalta now part of Shire 18
Not applicableUnknownNCT04180657
What this trial is testing

Ghrelin Levels in Patients With Protein C Deficiency

Who this might be right for
Protein C Deficiency
University of Aarhus 60
Large-scale testing (Phase 3)Ended earlyNCT05092360
What this trial is testing

Phase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab in Patients With Platinum-Resistant Epithelial Ovarian Cancer (ARTISTRY-7)

Who this might be right for
Platinum-resistant Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Mural Oncology, Inc 456
Early research (Phase 1)Looking for participantsNCT07470853
What this trial is testing

MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

Who this might be right for
PROCPlatinum Resistant Ovarian CancerEndometrial Cancer
Whitehawk Therapeutics, Inc. 265
Early research (Phase 1)Study completedNCT01660230
What this trial is testing

Safety and Pharmacokinetics of Single and Multiple Ascending Doses of 3K3A-APC in Healthy Adult Volunteers

Who this might be right for
Healthy
ZZ Biotech, LLC 64
Testing effectiveness (Phase 2)Looking for participantsNCT06526819
What this trial is testing

SMP-3124LP in Adults With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Sumitomo Pharma America, Inc. 120
Large-scale testing (Phase 3)Active Not RecruitingNCT06619236
What this trial is testing

Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer

Who this might be right for
Platinum-resistant Ovarian Cancer
Genmab 530
Not applicableStudy completedNCT06482866
What this trial is testing

Synechie Afrer Rhinosug. Proc. 2024

Who this might be right for
Complication of Surgical Procedure
Mateusz Jan Stępiński 243
Testing effectiveness (Phase 2)Study completedNCT04984889
What this trial is testing

TAK-662 for Japanese Patients With Congenital Protein C Deficiency

Who this might be right for
Congenital Protein C Deficiency
Takeda 5
Large-scale testing (Phase 3)WithdrawnNCT05484154
What this trial is testing

Efficacy and Safety Evaluation of 3K3A-APC in Ischemic Stroke

Who this might be right for
Ischemic Stroke
ZZ Biotech, LLC
Testing effectiveness (Phase 2)Ended earlyNCT03311334
What this trial is testing

DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid Tumors

Who this might be right for
Renal Cell Carcinoma (RCC)Urothelial CarcinomaPrimary Peritoneal Cancer+3 more
Sumitomo Pharma America, Inc. 47
Not applicableStudy completedNCT01806428
What this trial is testing

Activated Protein C and Microcirculation

Who this might be right for
Severe SepsisSeptic Shock
Università Politecnica delle Marche 22
Post-approval studies (Phase 4)Study completedNCT01017107
What this trial is testing

Activated Protein C in Severe Acute Pancreatitis

Who this might be right for
Acute Pancreatitis
Helsinki University Central Hospital 32
Large-scale testing (Phase 3)Study completedNCT00625209
What this trial is testing

Activated Protein C and Corticosteroids for Human Septic Shock

Who this might be right for
Septic Shock
University of Versailles 1,241
Not applicableUnknownNCT03625726
What this trial is testing

Rôle of the Soluble Endothelial Protein C Receptor in Cirrhosis-associated Hypercoagulability State (EXERCISE)

Who this might be right for
Cirrhosis
University Hospital, Clermont-Ferrand 300
Load More Results